1. Home
  2. NVAX vs NNE Comparison

NVAX vs NNE Comparison

Compare NVAX & NNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • NNE
  • Stock Information
  • Founded
  • NVAX 1987
  • NNE 2022
  • Country
  • NVAX United States
  • NNE United States
  • Employees
  • NVAX N/A
  • NNE N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • NNE
  • Sector
  • NVAX Health Care
  • NNE
  • Exchange
  • NVAX Nasdaq
  • NNE NYSE
  • Market Cap
  • NVAX 1.3B
  • NNE 1.4B
  • IPO Year
  • NVAX 1995
  • NNE 2024
  • Fundamental
  • Price
  • NVAX $6.84
  • NNE $35.10
  • Analyst Decision
  • NVAX Buy
  • NNE Strong Buy
  • Analyst Count
  • NVAX 5
  • NNE 2
  • Target Price
  • NVAX $16.60
  • NNE $50.50
  • AVG Volume (30 Days)
  • NVAX 4.9M
  • NNE 3.6M
  • Earning Date
  • NVAX 08-07-2025
  • NNE 08-13-2025
  • Dividend Yield
  • NVAX N/A
  • NNE N/A
  • EPS Growth
  • NVAX N/A
  • NNE N/A
  • EPS
  • NVAX 2.97
  • NNE N/A
  • Revenue
  • NVAX $1,254,962,000.00
  • NNE N/A
  • Revenue This Year
  • NVAX $56.85
  • NNE N/A
  • Revenue Next Year
  • NVAX N/A
  • NNE N/A
  • P/E Ratio
  • NVAX $2.30
  • NNE N/A
  • Revenue Growth
  • NVAX 25.92
  • NNE N/A
  • 52 Week Low
  • NVAX $5.01
  • NNE $6.30
  • 52 Week High
  • NVAX $17.81
  • NNE $48.05
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.12
  • NNE N/A
  • Support Level
  • NVAX $6.54
  • NNE N/A
  • Resistance Level
  • NVAX $7.20
  • NNE N/A
  • Average True Range (ATR)
  • NVAX 0.28
  • NNE 0.00
  • MACD
  • NVAX 0.06
  • NNE 0.00
  • Stochastic Oscillator
  • NVAX 66.36
  • NNE 0.00

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About NNE NANO NUCLEAR ENERGY INC

Nano Nuclear Energy Inc is an early-stage nuclear energy company developing smaller, cheaper, and safer portable clean energy solutions. It is focused on four business lines as part of development-Micro Nuclear Reactor Business is developing the next-generation nuclear microreactors, in particular ZEUS, a solid core battery reactor, and ODIN, a low-pressure salt coolant reactor; Fuel Processing Business; Fuel Fabrication Business; Fuel Transportation Business, and Nuclear Consultation Services.

Share on Social Networks: